Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that originated in Wuhan, China, in December 2019 has impacted public health, society, the global economy, and the daily lives of billions of people in an unprecedented manner. There are currently no specific registered antivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado-Benvindo, Clarisse, Thaler, Melissa, Tas, Ali, Ogando, Natacha S., Bredenbeek, Peter J., Ninaber, Dennis K., Wang, Ying, Hiemstra, Pieter S., Snijder, Eric J., van Hemert, Martijn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526844/
https://www.ncbi.nlm.nih.gov/pubmed/32513797
http://dx.doi.org/10.1128/AAC.00900-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526844/
https://www.ncbi.nlm.nih.gov/pubmed/32513797
http://dx.doi.org/10.1128/AAC.00900-20

Ejemplares similares